Literature DB >> 28933575

Unexpected uterine leiomyosarcoma in a woman with multiple myomas treated with ulipristal acetate: case report and literature review.

Paola Modaffari1, Marta D'alonzo1, Marta Garbagnati1, Silvia Pecchio1, Guido Menato1, Nicoletta Biglia1.   

Abstract

Ulipristal acetate (UPA) has been recognized as an alternative strategy to surgery in the management of symptomatic women with uterine fibroids. We present a case report on a woman with hereditary fibrinogen deficiency exclusively treated with UPA for myoma-related menorrhagia and abdominal pain, who subsequently underwent a hysterectomy because of clinical worsening. A FIGO IB uterine leiomyosarcoma was found among multiple myomas. A review of the literature found two other cases of uterine leiomyosarcoma in patients treated with UPA: clinical data are reported. The aim of this case report is to increase clinicians' awareness that, although rare, leiomyosarcoma can develop in a uterus with multiple myomas and no reliable diagnostic tools exist yet. Thus, a clinical and instrumental careful reevaluation and patient counseling should be a priority when planning to repeat UPA treatment cycles.

Entities:  

Keywords:  ulipristal acetate; uterine leiomyosarcoma; uterine myoma

Mesh:

Substances:

Year:  2017        PMID: 28933575     DOI: 10.1080/09513590.2017.1380186

Source DB:  PubMed          Journal:  Gynecol Endocrinol        ISSN: 0951-3590            Impact factor:   2.260


  1 in total

1.  Failure of ulipristal acetate treatment as an indication for uterine malignancy: Two case reports.

Authors:  Angela Santoro; Giuseppe Angelico; Damiano Arciuolo; Frediano Inzani; Francesco Fanfani; Daniela Romualdi; Giovanni Scambia; Gian Franco Zannoni
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.